SCHEMBL2492728

SCHEMBL2492728

Fc1cccc(F)c1Oc1ccnc(-c2sc(Nc3ccncc3)nc2-c2ccncc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.38
KDR P35968 1/20 0.37
CHRNA7 P36544 1/20 0.37
GCK P35557 1/20 0.37
CYP1A1 P04798 3/20 0.37
CYP1A2 P05177 3/20 0.37
CYP1B1 Q16678 3/20 0.37
CDK5 Q00535 3/20 0.36
CDK5R1 Q15078 3/20 0.36
ADORA3 P0DMS8 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CCNT1 O60563 1/20 0.33
CDK9 P50750 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2493333 0.85 KDR (0.43) PDE10AKDRCYP1A1CYP1A2CYP1B1
SCHEMBL2493080 0.78 KCNN1 (0.42) KDRGCKCDK5CDK5R1NPC1
SCHEMBL190433 0.71 RAB9A (0.55) GCKCYP1A1CYP1A2CYP1B1SMN1; SMN2
SCHEMBL6281996 0.65 MAPT (0.62) CYP1A1CYP1B1SMN1; SMN2NPC1POLB
SCHEMBL190426 0.65 KCNN1 (0.61) CYP1A1CYP1A2CYP1B1SMN1; SMN2NPC1
SCHEMBL190602 0.65 NPC1 (0.58) GCKCYP1A1CYP1A2CYP1B1SMN1; SMN2
SCHEMBL191394 0.64 RAB9A (0.58) CYP1A1CYP1A2CYP1B1SMN1; SMN2NPC1
SCHEMBL12305708 0.63 GCK (0.47) PDE10AKDRGCKSMN1; SMN2NPC1
SCHEMBL190888 0.63 GCK (0.51) GCKPOLBMAPT
SCHEMBL191840 0.63 RAB9A (0.47) GCKSMN1; SMN2NPC1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022222-B2 Glucokinase activators ARRAY BIOPHARMA, INC. (US) 2011-09-20 US disclosed